New hope for tough blood cancers: first human trial of GLB-001 begins
Disease control
Recruiting now
This early-stage trial tests an experimental oral drug called GLB-001 in adults whose acute myeloid leukemia (AML) or high-risk myelodysplastic syndromes (MDS) have come back or not responded to treatment. The study aims to find a safe dose and see if the drug shows any signs of …
Phase: PHASE1 • Sponsor: GluBio Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC